Information Library

Results for: Brochures - Oncology

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Accelerating Success in Oncology

    March 9, 2012
    New Demands to Demonstrate Value Require New Strategy Proof of efficacy is no longer enough to ensure success in oncology. As the cost and complexity

  • Oncology Experience

    February 7, 2012
    Quintiles acquires Outcome to offer full spectrum of inventional and observational research. Together, we offer the expertise and experience in real-world and late phase research

  • Turkey Oncology Capabilities

    February 6, 2012
    Turkey has outstanding access to patients with a population of almost 75 million. Quintiles recent experience demonstrates Turkey provides rapid patient enrollment with high patient retention rates and remains an emerging market with few competing studies – becoming a major hub for patient recruitment.

  • Middle East Oncology capabilities

    February 6, 2012
    Outstanding access to patients in the Middle East region with a population of over 200 million means this is an important emerging region for the biopharmaceutical industry and Quintiles has a proven track record of rapid patient enrollment with high patient retention rates.

  • Re-ignite Product Development and Sales with Data Insights: Fueling Innovation Fact Sheet

    November 17, 2011
    What Will Drive Biopharma’s Future? The long-dreaded crisis is staring us all in the face: What will take the place of expiring blockbusters with few prospects in hand? Spending on R&D more than doubled after 2002, but the output doesn’t match the investment. The number of new molecular entities has remained a disappointment, averaging only around 20 per year in the US. The big question is how can drug developers carve out a strategic path to innovation?

  • Genomics Fact Sheet

    June 17, 2011
    Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area.

  • Translational R&D Services Fact Sheet

    May 26, 2011
    Quintiles’ Translational R&D Center of Excellence performs groundbreaking research and offers novel findings in oncology for biopharmaceutical companies.

  • Clinical – Smarter Trials, Accelerated Outcomes

    February 16, 2011
    Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues.

  • Oncology Expertise - Scientific Collaborator for Global Solutions

    January 28, 2011
    Whether you wish to use one of our existing assays, need assistance with developing a new assay, or plan to deploy an assay developed by your diagnostic partner, as your collaborator, Quintiles has the scientific expertise, resources, and flexibility to develop the right solution for you.

  • Targeting Oncology

    June 2, 2010
    Learn more about Quintiles leadership in oncology product development and commercialization.

Page 1 of 2 (14 results)

Subscribe to Email Based on Your Interests

Set preferences